RxDoctor Payments Data

Garry Grayson, MD

Psychiatry · Birmingham, ALNPI 1043260409

Payments from drug & device makers

$854in general payments, 2019–2025

Across 43 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$200
  • Sunovion Pharmaceuticals Inc.$169
  • AbbVie$147
  • Otsuka America Pharmaceutical, Inc.$79
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • Neurocrine Biosciences, Inc.$38
  • plus $172 from 8 others

What the payments were for

  • Food & beverage$854100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$854 in reported general payments places this provider in the 50th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$28,061
Medicare patients
113
Services billed
286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorpromazine Hcl264$38,201
Invega SustennaPaliperidone Palmitate13$27,224
Naltrexone Hcl182$15,380
Quetiapine Fumarate610$14,957
Divalproex Sodium262$7,892
Lorazepam442$7,349
Divalproex Sodium ErDivalproex Sodium165$7,134
Olanzapine259$6,787
Clonazepam453$6,677
XanaxAlprazolam11$6,457
Ziprasidone Hcl60$5,167
Lurasidone Hcl24$4,729
Fluoxetine Hcl303$4,635
Risperidone254$4,232
Mirtazapine242$3,931

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$35$27,22413 claims
Teva Pharmaceuticals USA, Inc.Loxapine$14$56812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →